SLS (3205.TWO) monthly revenue, September 2026

SLS reported revenue of NT$35.8 million for September 2026, up 1.5% from the previous month and up 71.1% from a year earlier. Year-to-date revenue was NT$437.7 million, up 42.8% year on year. It ranked 18 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.

中文版

MonthRevenue NT$bnMoM %YoY %
September 20260.041.571.1